Wednesday, February 04, 2026 HDC1 three year follow up on the National Cancer Trials Network (NCTN) phase three S1826 trialCastellino SM, Li H, Herrera AF, LeBlanc M, Parsons SK, Unger JM, Punnett A, Hodgson D, Keller FG, Drachtman RA, Lamble A, Forlenza CJ, Doan A, Rutherford SC, Evens AM, Little RF, Smith MA, Hoppe BS, Song JY, Smith SM, Friedberg JW, Kelly KM. Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826 (ONLINE). Journal of Clinical Oncology JCO-25-00203. 2026. https://ascopubs.org/doi/abs/10.1200/JCO-25-00203
